Similar activation models can strengthen trial recruitment, precision medicine, and population health by converting data into ...
Cardinal Health's Michelle Britt discusses how independent pharmacies are expanding clinical services and leaning on ...
AMCP's Adam Colborn discusses survey findings on TrumpRx's six-month performance, examining payer skepticism about pricing ...
EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...
In this week's Pharma Pulse, Trump nominates Heidi Overton to lead the FDA, EVERSANA expands its AI-powered commercialization platform into medical affairs and market research, Moderna and Merck's ...
AI in PV can compress the interval between signal observation and documented action, preserving benefit–risk integrity and reducing the chance of safety issues becoming uncontrolled commercial events.
Trump is expected to pick White House aide Dr. Heidi Overton to lead the FDA, pending Senate confirmation, as the agency works to rebuild industry trust. Overton is among three finalists for the role, ...
Cardinal Health's Michelle Britt discusses the operating costs, cash flow strain and reimbursement pressures facing ...
Ten PBMs will integrate TrumpRx cash pricing into RTBT displays, allowing prescribers and patients to compare cash-pay versus plan benefit costs at the point of prescribing. Clinician workflow remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results